Growth Metrics

Soleno Therapeutics (SLNO) Cash from Operations (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -46.66%
Dec 31, 2025 11.98%
Sep 30, 2025 443.88%
Jun 30, 2025 61.38%
Mar 31, 2025 -36.52%
Dec 31, 2024 -60.73%
Sep 30, 2024 15.44%
Jun 30, 2024 -40.89%
Mar 31, 2024 -98.42%
Dec 31, 2023 0.28%
Sep 30, 2023 -13.76%
Jun 30, 2023 17.27%
Mar 31, 2023 -30.82%
Dec 31, 2022 -10.46%
Sep 30, 2022 -0.78%
Jun 30, 2022 27.38%
Mar 31, 2022 7.30%
Dec 31, 2021 -26.95%
Sep 30, 2021 32.53%
Jun 30, 2021 -7.01%
Mar 31, 2021 -9.04%
Dec 31, 2020 -11.40%
Sep 30, 2020 5.66%
Jun 30, 2020 -15.46%
Mar 31, 2020 -11.49%
Dec 31, 2019 -7.57%
Sep 30, 2019 -21.22%
Jun 30, 2019 -5.59%
Mar 31, 2019 1.31%
Dec 31, 2018 -39.56%
Sep 30, 2018 2.65%
Jun 30, 2018 -9.13%
Mar 31, 2018 -942.81%
Dec 31, 2017 107.91%
Sep 30, 2017 -200.56%
Jun 30, 2017 42.42%
Mar 31, 2017 -67.32%
Dec 31, 2016 -163.12%
Sep 30, 2016 151.18%
Jun 30, 2016 -1.38%
Mar 31, 2016 -17.93%
Dec 31, 2015 -18.08%
Sep 30, 2015 -27.10%
Jun 30, 2015 -24.43%
Mar 31, 2015 -16.23%
Dec 31, 2014 -23.33%
Sep 30, 2014 -9.08%
Jun 30, 2014 -127.31%
Mar 31, 2014 29.52%